Validation of Chinese SRI Questionnaire

Validation of Chinese Severe Respiratory Insufficiency （SRI）Questionnaire for COPD Patients With Chronic Hypercapnic Respiratory Failure

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02240225

Acronym

VCSRI

Enrollment

150

Registered

2014-09-15

Start date

2014-01-31

Completion date

2014-10-31

Last updated

2014-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease, Hypercapnic Respiratory Failure

Keywords

COPD;SRI;Reliability;validity;

Brief summary

Assessment of health-related quality of life in COPD patients with severe chronic respiratory failure requires appropriate and highly specific measurement tools. We attempt to validate the Chinese version of the Severe Respiratory Insufficiency Questionnaire (SRI)

Interventions

None listed

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

1. Adult COPD Patients with chronic hypercapnic respiratory failure established on home noninvasive ventilation for at least 1 month 2. Patients are in a clinically stable state,without any changes of medication during the previous 4 weeks.

Exclusion criteria

1. patient's refusal to participate 2. Patients with evidence of acute respiratory failure i.e.patients with worsening of symptoms during the previous 2 weeks, a pH ,7.35, or with signs of respiratory infection

Design outcomes

Primary

Measure	Time frame
Reliability of Severe Respiratory Insufficiency Questionnaire	2 weeks

Secondary

Measure	Time frame
Construct validity of Severe Respiratory Insufficiency Questionnaire	2 weeks
Criterion validity of Severe Respiratory Insufficiency Questionnaire	2 weeks

Countries

China

Contacts

Primary ContactZhou LuQian, Doctor

zhlx09@163.com+86-15622236759

Outcome results